Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
Comparative assessment of cough capacity in patients with neuromuscular disease: Spirometer versus portable peak flow
A Balañá Corberó1, J Martínez Llorens2
1Servei de Pneumologia, Hospital del Mar, Barcelona, Cataluña, Spain; Unidad de Esclerosis Lateral Amiotrófica, Hospital del Mar, Barcelona, Cataluña, Spain.
Introduction:
Cough impairment in neuromuscular diseases (NMD) increases pulmonary infection risk. Peak cough flow (PCF) is crucial for assessment, with spirometry (PCFs) as gold standard. Portable peak flow meters (PCFp) are practical, yet their comparability with spirometers in NMD remains debated. This study compared PCFs and PCFp in NMD patients with restrictive lung disease.
Methods:
A prospective, cross-sectional observational study included patients with NMD from a home mechanical ventilation unit. Inclusion criteria comprised a definitive diagnosis of NMD and the ability to perform forced expiratory maneuvers. PCF was measured using a calibrated spirometer (PCFs) and a portable peak flow meter (PCFp) in randomized order. The measurement protocol followed ATS/ERS 2019 standards. Agreement was evaluated using the Bland-Altman method and the Intraclass Correlation Coefficient (ICC). Data normality was assessed by the Shapiro-Wilk test. A p-value<0.05 was considered statistically significant.
Results:
Sixty-seven patients (62.1±14.9 years; 46.3% female) with various NMD where included. No significant difference was found between mean PCFs (314.5±98.5L/min) and PCFp (301.6±100.1L/min) (p=0.4535). The ICC was 0.92 (95% CI 0.88-0.95). The Bland-Altman analysis indicated a mean difference of 12.9L/min (limits of agreement ranged from -52.7L/min to 78.5L/min). A strong correlation was observed (r=0.949, p<0.001). Impaired cough capacity (35.8% of patients) was linked to older age and poorer function. No device differences were found within subgroups.
Conclusion:
PCPp demonstrates an acceptable level of agreement with PCPs in NMD patients. PCPp is a reliable and accessible screening tool for home monitoring. However, the wide limits of agreement observed necessitate further studies involving larger, possibly specific, patient populations to definitively establish the full clinical interchangeability required for therapeutic decision-making.
More Related Videos
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration...
Assessment of Airway, Skin Color, and Use of Accessory Muscles
Introduction
The initial evaluation of a patient's respiratory system...
Respiratory Volumes and Capacities I
Respiratory Volumes and Capacities

